GeoVax Labs (GOVX) said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.
Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.
The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.
Shares of the company were down over 21% in Tuesday trading.
Price: 0.84, Change: -0.23, Percent Change: -21.50
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。